10.3389/fpls.2019.00608 Front
BPC-157: The Angiogenic Healer BPC-157's healing effects center on blood vessel formation and cytoprotection: VEGF Upregulation: Increases vascular endothelial growth factor, promoting new blood vessel formation to injured tissues (PMID: 27847966, PMID: 40789979) Nitric Oxide System: Modulates NO pathways, protecting tissues from oxidative damage and improving blood flow (PMID: 31158953) Growth Factor Pathways: Interacts with and functionally engages growth-factordependent cytoprotective and regenerative pathways, producing growth-factorlike effects (PMID: 11718984, PMID: 40789979) Cytoprotective: Protects cells from various toxic insults including NSAIDs, alcohol, and ischemia (PMID: 31158953) Nerve Healing: BPC-157 indirectly modulates GABAergic inhibitory control, supporting nerve regeneration (PMID: 15840402) TB-500: The Cell Migration Facilitator TB-500 is a synthetic peptide designed to mimic Thymosin -4, which is well-established in actin sequestration, cell migration, wound repair, and anti-inflammatory signaling
Dosing & Reconstitution Guide Educational guide for reconstitution and daily dosing Standard / Gradual Approach (3 mL = ~6.67 mg/mL total) Route: Subcutaneous injection | Frequency: Once daily For 10-unit (0.10 mL) administrations during Weeks 14, consider using 30- or 50-unit insulin syringes for improved readability
New Zealand Research has primarily focused on its mechanisms of action, which suggest an enhancement in the processes of angiogenesis (the development of new blood vessels), tissue granulation, and collagen reformation
